TrialDiabetes, obesity & metabolism2026

Efficacy and Safety of Crisugabalin for Inadequately Controlled Diabetic Peripheral Neuropathic Pain: A Randomized, Active-Controlled, Phase 2 Trial.

Yaming Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.